Novel mechanism of resistance to paclitaxel (Taxol®) in human K562 leukemia cells by combined selection with PSC 833

Oncology Research

Volumn 7, Issue 10-11, 1995, Pages 517-527

  Jaffrézou, Jean Pierre ^a   Dumontet, Charles ^a   Derry, W Brent ^b   Durán, George ^a   Chen, Gang ^a   Tsuchiya, Etsuko ^b   Wilson, Leslie ^b   Jordan, Mary Ann ^b   Sikic, Branimir I ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

drug resistance; microtubules; paclitaxel; PSC 833; Taxol; tubulin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA TUBULIN; BLEOMYCIN; CISPLATIN; COLCHICINE; CYCLOSPORIN DERIVATIVE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; METHOTREXATE; MITOXANTRONE; MONOCLONAL ANTIBODY; NAVELBINE; PACLITAXEL; PODOPHYLLOTOXIN; TUBULIN; VALSPODAR; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; MICROTUBULE; MITOSIS SPINDLE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029550441     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)